# Evaluation of STARgraft AV for Hemodialysis Access

> **NCT03916731** · NA · COMPLETED · sponsor: **Healionics Corporation** · enrollment: 55 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DEVICE:** STARgraft AV
- **DEVICE:** ePTFE AV graft (control)

## Key facts

- **NCT ID:** NCT03916731
- **Lead sponsor:** Healionics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-02
- **Primary completion:** 2020-10-17
- **Final completion:** 2021-05-11
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2024-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03916731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03916731, "Evaluation of STARgraft AV for Hemodialysis Access". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03916731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*